Temsirolimus in women with platinum-resistant ovarian cancer or advanced/recurrent endometrial cancer: a multicenter phase II trial of the AGO Study Group (AGO-GYN 8)

2014 ◽  
Vol 74 (S 01) ◽  
Author(s):  
F Hilpert ◽  
C Kurzeder ◽  
B Schmalfeldt ◽  
P Neuser ◽  
N de Gregorio ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Endometrial Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Study Group ◽  
Multicenter Phase ◽  
Platinum Resistant ◽  
Recurrent Endometrial Cancer

Temsirolimus in women with platinum-resistant ovarian cancer or advanced/recurrent endometrial cancer: A multicenter phase II trial of the AGO Study Group (AGO-GYN 8).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 5565-5565 ◽  
Author(s):  
Guenter Emons ◽  
Christian Kurzeder ◽  
Barbara Schmalfeldt ◽  
Alexander Reuss ◽  
Nikolaus de Gregorio ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Endometrial Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Study Group ◽  
Multicenter Phase ◽  
Platinum Resistant ◽  
Recurrent Endometrial Cancer

Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer

2004 ◽  
Vol 54 (4) ◽  
pp. 283-289 ◽  
Author(s):  
Robert J. Morgan ◽  
Timothy W. Synold ◽  
David Gandara ◽  
Franco Muggia ◽  
Sidney Scudder ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Recurrent Ovarian Cancer ◽  
Platinum Resistant
Sign in / Sign up

Export Citation Format

Share Document